News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Lumen Bioscience Announces $5.5 Million Funding to Support New Research Program for Mucosal Vaccine Platform Technology
Seattle-based biotech company Lumen Bioscience (Lumen) received $5.5 million from the U.S. Department of Defense to support its research and development of needleless vaccines. Lumen’s
Careers in Biotech: Creating Change and Opportunity
Snehal Patel, Head of Technical Operations at Sana Biotechnology (Sana), discusses his day-to-day work, his experience living and working in Washington, and his passion for
Paul Allen foundation awards millions for biological research
The Paul G. Allen Family Foundation, based in Seattle, is awarding roughly $10.5 million to several research initiatives. Established in 1988, the foundation funds projects
Phase Genomics Advances Breakthrough Cytogenomics with the Element AVITI System for Acute Myeloid Leukemia
Seattle-based biotech company Phase Genomics released new data from its OncoTerra platform and ATIVI sequencing system, which aim to provide innovative, rapid risk assessment for
Biotech around the World: The West Coast of the United States
GEN, Genetic Engineering & Biotechnology News, begins its Biotech around the World series with a feature on the West Coast of the United States. Through
University of Wash. Bothell and Cascadia College celebrate new STEM-focused Innovation Hall
The University of Washington Bothell and Cascadia College announced at a celebratory event their shared Innovation Hall, which will support students specializing in chemistry, computer
New website helps engineers find biomedical challenges that crown winning algorithms
Seattle nonprofit Sage Bionetworks released a new site called OpenChallenges that allows users to post biomedical challenges and potential algorithmic solutions. The free site meets
Lincoln Property Company’s Nearly 200,000 SQFT Life Science Building in Seattle Tops Out
Lincoln Property Company (LPC) and Intercontinental Real Estate Corporation celebrated the topping out of a new life science building in Seattle. Located at 222 Fifth
US FDA approves Bristol-Myers’ lung cancer drug
Pharmaceutical company Bristol-Myers Squibb received FDA approval for Augtyro, a drug developed to treat lung cancer. The approval comes after the drug, was successful in
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed Allogeneic CAR T Therapy, for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated Vasculitis
Seattle-based company Sana Biotechnology (Sana) received FDA clearance for its Investigational New Drug application aimed at treating “patients with multiple B-cell mediated autoimmune diseases,” according
Alpine Immune Sciences raising $150M through public offering
Alpine Immune Sciences Inc., a biotech company based in Seattle, has raised $150 million through underwritten public funding. According to Alpine, the new funding brings
BioLife Solutions raises $10.4M through private placement
BioLife Solutions Inc., a biological material storage business based in Bothell, Washington, received $10.4 million in funding from Casdin Capital, an investment firm based out